We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$32.9B
AUM Growth
-$855M
Cap. Flow
-$1.68B
Cap. Flow %
-5.1%
Top 10 Hldgs %
29.62%
Holding
1,163
New
73
Increased
397
Reduced
461
Closed
98

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$87.5M
2
SHW icon
Sherwin-Williams
SHW
+$76.1M
3
HD icon
Home Depot
HD
+$68M
4
LIN icon
Linde
LIN
+$55M
5
BMY icon
Bristol-Myers Squibb
BMY
+$50.3M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$95.3M
2
AAPL icon
Apple
AAPL
+$83.2M
3
AVGO icon
Broadcom
AVGO
+$76.2M
4
ELV icon
Elevance Health
ELV
+$71.4M
5
NVDA icon
NVIDIA
NVDA
+$69.2M

Sector Composition

Rank Sector Weight
1 Technology 37.44%
2 Healthcare 14.27%
3 Consumer Discretionary 12.23%
4 Financials 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
301
Charles Schwab
SCHW
$186B
$17.3M 0.05%
234,160
+74,350
+47% +$5.56M
BXP icon
302
Boston Properties
BXP
$10.2B
$17M 0.05%
228,193
+10,026
+5% +$813K
UTHR icon
303
United Therapeutics
UTHR
$21.5B
$16.9M 0.05%
47,812
-15,037
-24% -$5.53M
GL icon
304
Globe Life
GL
$13.3B
$16.7M 0.05%
150,040
+100,856
+205% +$10.9M
PEG icon
305
Public Service Enterprise Group
PEG
$35.1B
$16.7M 0.05%
197,667
+3,902
+2% +$345K
BALL icon
306
Ball Corp
BALL
$16.1B
$16.7M 0.05%
302,288
+24,373
+9% +$1.49M
ESTC icon
307
Elastic
ESTC
$8.94B
$16.5M 0.05%
166,867
-2,285
-1% -$211K
WSO icon
308
Watsco Inc
WSO
$12.5B
$16.5M 0.05%
34,881
-9
-0% -$4.56K
SBUX icon
309
Starbucks
SBUX
$110B
$16M 0.05%
175,200
-209,425
-54% -$20.3M
BR icon
310
Broadridge
BR
$19.4B
$15.7M 0.05%
69,554
+14,703
+27% +$3.29M
REG icon
311
Regency Centers
REG
$13.6B
$15.7M 0.05%
212,666
-11,848
-5% -$867K
FNV icon
312
Franco-Nevada
FNV
$50.7B
$15.7M 0.05%
133,543
+11,968
+10% +$1.48M
INSM icon
313
Insmed
INSM
$26.2B
$15.7M 0.05%
226,821
-360
-0.2% -$25.9K
CBOE icon
314
Cboe Global Markets
CBOE
$28.2B
$15.4M 0.05%
78,778
+22,031
+39% +$4.54M
SHAK icon
315
Shake Shack
SHAK
$2.35B
$15.3M 0.05%
118,223
+101,242
+596% +$12.4M
IBN icon
316
ICICI Bank
IBN
$102B
$15.3M 0.05%
511,774
-3,170
-0.6% -$95.7K
KRNT icon
317
Kornit Digital
KRNT
$657M
$15.1M 0.05%
488,748
-11,363
-2% -$326K
IT icon
318
Gartner
IT
$12.4B
$15.1M 0.05%
31,073
+11,739
+61% +$6.05M
VTRS icon
319
Viatris
VTRS
$19.1B
$15M 0.05%
1,207,046
-293,541
-20% -$3.61M
CLX icon
320
Clorox
CLX
$10.5B
$14.8M 0.04%
91,086
+48,524
+114% +$7.94M
IQV icon
321
IQVIA
IQV
$44.4B
$14.7M 0.04%
74,826
+318
+0.4% +$67.1K
ASML icon
322
ASML
ASML
$611B
$14.7M 0.04%
21,172
-3,415
-14% -$2.45M
XOM icon
323
ExxonMobil
XOM
$696B
$14.6M 0.04%
136,098
-1,961
-1% -$229K
AFL icon
324
Aflac
AFL
$58.9B
$14.6M 0.04%
141,515
-30,424
-18% -$3.32M
NVO
325
Novo Nordisk
NVO
$188B
$14.5M 0.04%
168,195
+61,040
+57% +$6.6M

Similar funds

Axa's Q4 2024 Portfolio in Review

As of Q4 2024, Axa held 1,163 positions worth $32.9B, down 2.5% from $33.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Axa withdrew a net $1.68B in Q4 2024, closing 98 positions and reducing 461 holdings. Its most notable exit was Altair Engineering Inc, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in JBT Marel worth $34.4M.

  • Axa's largest Q4 2024 buy was JBT Marel: 270,829 shares worth $34.4M.
  • Axa added most to Salesforce in Q4 2024, an estimated $87.5M increase.
  • Axa's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $95.3M.
  • Axa fully exited Altair Engineering Inc in Q4 2024, selling an estimated $67.5M.
  • Axa's ten largest holdings make up 30% of its $32.9B portfolio in Q4 2024.
  • Axa opened 73 new positions and closed 98 in Q4 2024.
  • Axa's portfolio value fell 2.5% quarter-over-quarter to $32.9B.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.